Healthcare / Medical Care FacilitiesShenzhen
$2.13
-0.04 (-1.84%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $111.2M · quality 65.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
21/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.4B
P/E
213.0x
↑EV/EBITDA
21.1x
↑ROE
1.6%
↑Gross Margin
28.8%
↓Debt/Equity
0.96
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-1.2%
FCF CAGR
-7.5%
FCF margin
1.2%
FCF / Net income
1.19x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.05B · net income $30.9M · FCF $36.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.05B | $3.05B | $3.80B | $3.91B | $3.16B |
| Net Income | $30.9M | $30.9M | $114.8M | $27.0M | $156.1M |
| EBITDA | $401.7M | $401.7M | $505.2M | $367.8M | $496.7M |
| EPS | 0.01 | 0.01 | 0.03 | 0.01 | 0.05 |
| Gross Margin | 28.8% | 28.8% | 30.9% | 29.9% | 31.4% |
| Operating Margin | 9.0% | 9.0% | 9.1% | 6.5% | 9.5% |
| Net Margin | 1.0% | 1.0% | 3.0% | 0.7% | 4.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.96 | 0.96 | 0.89 | 0.84 | 0.92 |
| Current Ratio | 0.53 | 0.53 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $36.8M | $36.8M | $131.1M | $111.2M | $46.5M |
| Returns | |||||
| ROE | 1.6% | 1.6% | 5.8% | 1.3% | 9.1% |
| Valuation | |||||
| P/E | 213.00 | 213.00 | 75.36 | 365.00 | 84.94 |
| EV/EBITDA | 21.14 | 21.14 | 19.68 | 30.03 | 28.76 |
| P/B | 3.59 | 3.59 | 4.36 | 4.66 | 7.70 |
| Growth & Yield | |||||
| Revenue Growth | -19.6% | -19.6% | -2.9% | 23.8% | — |
| EPS Growth | -73.1% | -73.1% | 336.3% | -83.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
171.9%
EPS terminal req.
$0.19
Spread vs growth
-245.0%
5Y implied EPS CAGR
89.3%
EPS terminal req.
$0.23
Spread vs growth
-162.4%
10Y implied EPS CAGR
44.3%
EPS terminal req.
$0.37
Spread vs growth
-117.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-10.5%
Start / end P/E
68.2x → 226.6x
EPS bridge
0.03 → 0.01
Residual
-169.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.